PUBLISHER: KBV Research | PRODUCT CODE: 1353585
PUBLISHER: KBV Research | PRODUCT CODE: 1353585
North America Viscosupplementation Market Size, Share & Industry Trends Analysis Report By Application, By Product (Three Injection, Single Injection, and Five Injection), By End-use, By Country and Growth Forecast, 2023 - 2030
The North America Viscosupplementation Market would witness market growth of 8.2% CAGR during the forecast period (2023-2030).
Viscosupplementation aims to improve the knee's functional status and reduce joint pain. Viscosupplementation demand is significantly fuelled by the rising prevalence of osteoarthritis (OA). The main factor causing persistent disability is osteoarthritis, a chronic degenerative joint disability. the market is expected to be driven by the rising demand for non-surgical osteoarthritis treatments, the prevalence of lifestyle-related conditions, and advances in the development of hyaluronic acid-based therapies.
According to the Government of Canada's statistical report, the Canadian population in July 2019 included 6,592,611 seniors. In July 2019, seniors represented 17.5% of the Canadian population. Due to the aging impact, which reduces the flexibility and strength of the cartilage, there is a considerable increase in the geriatric population, making them more vulnerable to knee and hip osteoarthritis. The senior population also exhibits a shift in the cells and extracellular matrix of joint tissues, intensifying the imbalance between anabolic and catabolic activity.
In 2020, 3.9 million adult Canadians above the age of 20 were estimated to have arthritis, according to Statistics Canada. Arthritis is more common in older people and more prevalent in women. Furthermore, North America's market has experienced tremendous growth due to the high awareness of these treatments and the high prevalence of arthritis joint pain among adults in the United States and Canada, along with other co-occurring conditions like diabetes. Hence, the region presents lucrative growth prospects for the market.
The US market dominated the North America Viscosupplementation Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $1,699.8 million by 2030. The Canada market is experiencing a CAGR of 10.6% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 9.6% during (2023 - 2030).
Based on Application, the market is segmented into Knee Osteoarthritis, Hand Osteoarthritis, Hip Osteoarthritis, and Others. Based on Product, the market is segmented into Three Injection, Single Injection, and Five Injection. Based on End-use, the market is segmented into Hospitals, and Orthopedic Clinics/ASCs. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include DePuy Synthes (Johnson & Johnson), Sanofi S.A., Zimmer Biomet Holdings, Inc., Ferring Holdings SA, F. Hoffmann-La Roche Ltd., LG Chem Ltd. (LG Corporation), Anika Therapeutics, Inc., Fidia Farmaceutici S.p.A. (P&R Farmaceutici S.p.A), Smith & Nephew PLC and Seikagaku Corp.
Scope of the Study
Market Segments covered in the Report:
By Application
- Knee Osteoarthritis
- Hand Osteoarthritis
- Hip Osteoarthritis
- Others
By Product
- Three Injection
- Single Injection
- Five Injection
By End-use
- Hospitals
- Orthopedic Clinics/ASCs
By Country
- US
- Canada
- Mexico
- Rest of North America
Companies Profiled
- DePuy Synthes (Johnson & Johnson)
- Sanofi S.A.
- Zimmer Biomet Holdings, Inc.
- Ferring Holdings SA
- F. Hoffmann-La Roche Ltd.
- LG Chem Ltd. (LG Corporation)
- Anika Therapeutics, Inc.
- Fidia Farmaceutici S.p.A. (P&R Farmaceutici S.p.A)
- Smith & Nephew PLC
- Seikagaku Corp.
Unique Offerings from KBV Research
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 North America Viscosupplementation Market, by Application
- 1.4.2 North America Viscosupplementation Market, by Product
- 1.4.3 North America Viscosupplementation Market, by End-use
- 1.4.4 North America Viscosupplementation Market, by Country
- 1.5 Methodology for the research
Chapter 2. Market At a Glance
- 2.1 Key Highlights
Chapter 3. Market Overview
- 3.1 Introduction
- 3.1.1 Overview
- 3.1.1.1 Market Composition and Scenario
- 3.1.1 Overview
- 3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.3 Porter's Five Force Analysis
Chapter 4. North America Viscosupplementation Market by Application
- 4.1 North America Knee Osteoarthritis Market by Country
- 4.2 North America Hand Osteoarthritis Market by Country
- 4.3 North America Hip Osteoarthritis Market by Country
- 4.4 North America Others Market by Country
Chapter 5. North America Viscosupplementation Market by Product
- 5.1 North America Three Injection Market by Country
- 5.2 North America Single Injection Market by Country
- 5.3 North America Five Injection Market by Country
Chapter 6. North America Viscosupplementation Market by End-use
- 6.1 North America Hospitals Market by Country
- 6.2 North America Orthopedic Clinics/ASCs Market by Country
Chapter 7. North America Viscosupplementation Market by Country
- 7.1 US Viscosupplementation Market
- 7.1.1 US Viscosupplementation Market by Application
- 7.1.2 US Viscosupplementation Market by Product
- 7.1.3 US Viscosupplementation Market by End-use
- 7.2 Canada Viscosupplementation Market
- 7.2.1 Canada Viscosupplementation Market by Application
- 7.2.2 Canada Viscosupplementation Market by Product
- 7.2.3 Canada Viscosupplementation Market by End-use
- 7.3 Mexico Viscosupplementation Market
- 7.3.1 Mexico Viscosupplementation Market by Application
- 7.3.2 Mexico Viscosupplementation Market by Product
- 7.3.3 Mexico Viscosupplementation Market by End-use
- 7.4 Rest of North America Viscosupplementation Market
- 7.4.1 Rest of North America Viscosupplementation Market by Application
- 7.4.2 Rest of North America Viscosupplementation Market by Product
- 7.4.3 Rest of North America Viscosupplementation Market by End-use
Chapter 8. Company Profiles
- 8.1 DePuy Synthes (Johnson & Johnson)
- 8.1.1 Company Overview
- 8.1.2 Financial Analysis
- 8.1.3 Segmental & Regional Analysis
- 8.1.4 Research & Development Expenses
- 8.1.5 SWOT Analysis
- 8.2 Sanofi S.A.
- 8.2.1 Company Overview
- 8.2.2 Financial Analysis
- 8.2.3 Segmental and Regional Analysis
- 8.2.4 Research & Development Expense
- 8.2.5 SWOT Analysis
- 8.3 Zimmer Biomet Holdings, Inc.
- 8.3.1 Company Overview
- 8.3.2 Financial Analysis
- 8.3.3 Regional Analysis
- 8.3.4 Research & Development Expense
- 8.3.5 SWOT Analysis
- 8.4 Ferring Holdings SA
- 8.4.1 Company Overview
- 8.4.2 Financial Analysis
- 8.4.3 Regional Analysis
- 8.4.4 Research and Development Expense
- 8.4.5 SWOT Analysis
- 8.5 F. Hoffmann-La Roche Ltd.
- 8.5.1 Company Overview
- 8.5.2 Financial Analysis
- 8.5.3 Segmental and Regional Analysis
- 8.5.4 Research & Development Expense
- 8.5.5 SWOT Analysis
- 8.6 LG Chem Ltd. (LG Corporation)
- 8.6.1 Company Overview
- 8.6.2 Financial Analysis
- 8.6.3 Segmental and Regional Analysis
- 8.6.4 SWOT Analysis
- 8.7 Anika Therapeutics, Inc.
- 8.7.1 Company Overview
- 8.7.2 Financial Analysis
- 8.7.3 Regional Analysis
- 8.7.4 Research & Development Expenses
- 8.7.5 SWOT Analysis
- 8.8 Fidia Farmaceutici S.p.A. (P&R Farmaceutici S.p.A)
- 8.8.1 Company Overview
- 8.8.2 Financial Analysis
- 8.8.3 Regional Analysis
- 8.8.4 Research & Development Expenses
- 8.8.5 SWOT Analysis
- 8.9 Smith & Nephew PLC
- 8.9.1 Company Overview
- 8.9.2 Financial Analysis
- 8.9.3 Regional and Segmental Analysis
- 8.9.4 Research & Development Expense
- 8.9.5 SWOT Analysis
- 8.10. Seikagaku Corp.
- 8.10.1 Company Overview
- 8.10.2 Financial Analysis
- 8.10.3 Segmental Analysis
- 8.10.4 Research & Development Expenses
- 8.10.5 SWOT Analysis
LIST OF TABLES
- TABLE 1 North America Viscosupplementation Market, 2019 - 2022, USD Million
- TABLE 2 North America Viscosupplementation Market, 2023 - 2030, USD Million
- TABLE 3 North America Viscosupplementation Market by Application, 2019 - 2022, USD Million
- TABLE 4 North America Viscosupplementation Market by Application, 2023 - 2030, USD Million
- TABLE 5 North America Knee Osteoarthritis Market by Country, 2019 - 2022, USD Million
- TABLE 6 North America Knee Osteoarthritis Market by Country, 2023 - 2030, USD Million
- TABLE 7 North America Hand Osteoarthritis Market by Country, 2019 - 2022, USD Million
- TABLE 8 North America Hand Osteoarthritis Market by Country, 2023 - 2030, USD Million
- TABLE 9 North America Hip Osteoarthritis Market by Country, 2019 - 2022, USD Million
- TABLE 10 North America Hip Osteoarthritis Market by Country, 2023 - 2030, USD Million
- TABLE 11 North America Others Market by Country, 2019 - 2022, USD Million
- TABLE 12 North America Others Market by Country, 2023 - 2030, USD Million
- TABLE 13 North America Viscosupplementation Market by Product, 2019 - 2022, USD Million
- TABLE 14 North America Viscosupplementation Market by Product, 2023 - 2030, USD Million
- TABLE 15 North America Three Injection Market by Country, 2019 - 2022, USD Million
- TABLE 16 North America Three Injection Market by Country, 2023 - 2030, USD Million
- TABLE 17 North America Single Injection Market by Country, 2019 - 2022, USD Million
- TABLE 18 North America Single Injection Market by Country, 2023 - 2030, USD Million
- TABLE 19 North America Five Injection Market by Country, 2019 - 2022, USD Million
- TABLE 20 North America Five Injection Market by Country, 2023 - 2030, USD Million
- TABLE 21 North America Viscosupplementation Market by End-use, 2019 - 2022, USD Million
- TABLE 22 North America Viscosupplementation Market by End-use, 2023 - 2030, USD Million
- TABLE 23 North America Hospitals Market by Country, 2019 - 2022, USD Million
- TABLE 24 North America Hospitals Market by Country, 2023 - 2030, USD Million
- TABLE 25 North America Orthopedic Clinics/ASCs Market by Country, 2019 - 2022, USD Million
- TABLE 26 North America Orthopedic Clinics/ASCs Market by Country, 2023 - 2030, USD Million
- TABLE 27 North America Viscosupplementation Market by Country, 2019 - 2022, USD Million
- TABLE 28 North America Viscosupplementation Market by Country, 2023 - 2030, USD Million
- TABLE 29 US Viscosupplementation Market, 2019 - 2022, USD Million
- TABLE 30 US Viscosupplementation Market, 2023 - 2030, USD Million
- TABLE 31 US Viscosupplementation Market by Application, 2019 - 2022, USD Million
- TABLE 32 US Viscosupplementation Market by Application, 2023 - 2030, USD Million
- TABLE 33 US Viscosupplementation Market by Product, 2019 - 2022, USD Million
- TABLE 34 US Viscosupplementation Market by Product, 2023 - 2030, USD Million
- TABLE 35 US Viscosupplementation Market by End-use, 2019 - 2022, USD Million
- TABLE 36 US Viscosupplementation Market by End-use, 2023 - 2030, USD Million
- TABLE 37 Canada Viscosupplementation Market, 2019 - 2022, USD Million
- TABLE 38 Canada Viscosupplementation Market, 2023 - 2030, USD Million
- TABLE 39 Canada Viscosupplementation Market by Application, 2019 - 2022, USD Million
- TABLE 40 Canada Viscosupplementation Market by Application, 2023 - 2030, USD Million
- TABLE 41 Canada Viscosupplementation Market by Product, 2019 - 2022, USD Million
- TABLE 42 Canada Viscosupplementation Market by Product, 2023 - 2030, USD Million
- TABLE 43 Canada Viscosupplementation Market by End-use, 2019 - 2022, USD Million
- TABLE 44 Canada Viscosupplementation Market by End-use, 2023 - 2030, USD Million
- TABLE 45 Mexico Viscosupplementation Market, 2019 - 2022, USD Million
- TABLE 46 Mexico Viscosupplementation Market, 2023 - 2030, USD Million
- TABLE 47 Mexico Viscosupplementation Market by Application, 2019 - 2022, USD Million
- TABLE 48 Mexico Viscosupplementation Market by Application, 2023 - 2030, USD Million
- TABLE 49 Mexico Viscosupplementation Market by Product, 2019 - 2022, USD Million
- TABLE 50 Mexico Viscosupplementation Market by Product, 2023 - 2030, USD Million
- TABLE 51 Mexico Viscosupplementation Market by End-use, 2019 - 2022, USD Million
- TABLE 52 Mexico Viscosupplementation Market by End-use, 2023 - 2030, USD Million
- TABLE 53 Rest of North America Viscosupplementation Market, 2019 - 2022, USD Million
- TABLE 54 Rest of North America Viscosupplementation Market, 2023 - 2030, USD Million
- TABLE 55 Rest of North America Viscosupplementation Market by Application, 2019 - 2022, USD Million
- TABLE 56 Rest of North America Viscosupplementation Market by Application, 2023 - 2030, USD Million
- TABLE 57 Rest of North America Viscosupplementation Market by Product, 2019 - 2022, USD Million
- TABLE 58 Rest of North America Viscosupplementation Market by Product, 2023 - 2030, USD Million
- TABLE 59 Rest of North America Viscosupplementation Market by End-use, 2019 - 2022, USD Million
- TABLE 60 Rest of North America Viscosupplementation Market by End-use, 2023 - 2030, USD Million
- TABLE 61 Key Information - DePuy Synthes
- TABLE 62 Key Information - Sanofi S.A.
- TABLE 63 key Information - Zimmer Biomet Holdings, Inc.
- TABLE 64 key information - Ferring Holdings SA
- TABLE 65 Key Information - F. Hoffmann-La Roche Ltd.
- TABLE 66 key information - LG Chem Ltd.
- TABLE 67 Key Information - Anika Therapeutics, Inc.
- TABLE 68 Key Information - Fidia Farmaceutici S.p.A.
- TABLE 69 key Information - Smith & Nephew PLC
- TABLE 70 Key Information - Seikagaku Corp.
List of Figures
- FIG 1 Methodology for the research
- FIG 2 North America Viscosupplementation Market, 2019 - 2030, USD Million
- FIG 3 Key Factors Impacting the Viscosupplementation Market
- FIG 4 Porter's Five Force Analysis: Viscosupplementation Market
- FIG 5 North America Viscosupplementation Market share by Application, 2022
- FIG 6 North America Viscosupplementation Market share by Application, 2030
- FIG 7 North America Viscosupplementation Market by Application, 2019 - 2030, USD Million
- FIG 8 North America Viscosupplementation Market share by Product, 2022
- FIG 9 North America Viscosupplementation Market share by Product, 2030
- FIG 10 North America Viscosupplementation Market by Product, 2019 - 2030, USD Million
- FIG 11 North America Viscosupplementation Market share by End-use, 2022
- FIG 12 North America Viscosupplementation Market share by End-use, 2030
- FIG 13 North America Viscosupplementation Market by End-use, 2019 - 2030, USD Million
- FIG 14 North America Viscosupplementation Market share by Country, 2022
- FIG 15 North America Viscosupplementation Market share by Country, 2030
- FIG 16 North America Viscosupplementation Market by Country, 2019 - 2030, USD Million
- FIG 17 Swot Analysis: DePuy Synthes
- FIG 18 Swot Analysis: Sanofi S.A.
- FIG 19 Swot Analysis: Zimmer Biomet Holdings, Inc.
- FIG 20 Swot Analysis: Ferring Holdings SA
- FIG 21 Swot Analysis: F. Hoffmann-La Roche Ltd.
- FIG 22 Swot Analysis: LG Chem Ltd.
- FIG 23 Swot Analysis: ANIKA THERAPEUTICS, INC.
- FIG 24 Swot Analysis: FIDIA FARMACEUTICI S.P.A.
- FIG 25 SWOT Analysis: Smith & Nephew PLC
- FIG 26 Swot Analysis: SEIKAGAKU CORP.
